Cost effectiveness of caspofungin vs. voriconazole for empiric therapy in Turkey.

MLA

Turner, S. J., et al. “Cost Effectiveness of Caspofungin vs. Voriconazole for Empiric Therapy in Turkey.” Mycoses, vol. 57, no. 8, Aug. 2014, pp. 489–96. EBSCOhost, https://doi.org/10.1111/myc.12187.

APA

Turner, S. J., Senol, E., Kara, A., Al-Badriyeh, D., Dinleyici, E. C., & Kong, D. C. M. (2014). Cost effectiveness of caspofungin vs. voriconazole for empiric therapy in Turkey. Mycoses, 57(8), 489–496. https://doi.org/10.1111/myc.12187

Chicago

Turner, S J, E Senol, A Kara, D Al-Badriyeh, E C Dinleyici, and D C M Kong. 2014. “Cost Effectiveness of Caspofungin vs. Voriconazole for Empiric Therapy in Turkey.” Mycoses 57 (8): 489–96. doi:10.1111/myc.12187.